Medexus Pharmaceuticals Inc. (MEDXF)
OTCMKTS · Delayed Price · Currency is USD
2.170
-0.025 (-1.14%)
Sep 16, 2025, 12:38 PM EDT
Medexus Pharmaceuticals Market Cap
Medexus Pharmaceuticals has a market cap or net worth of $69.75 million as of September 17, 2025. Its market cap has increased by 56.20% in one year.
Market Cap
69.75M
Enterprise Value
82.21M
Revenue
105.66M
Ranking
n/a
PE Ratio
86.54
Stock Price
$2.17
Market Cap Chart
Since December 27, 2013, Medexus Pharmaceuticals's market cap has increased from 30.10M to 69.75M, an increase of 131.71%. That is a compound annual growth rate of 7.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 69.75M | 17.43% |
| Dec 31, 2024 | 59.40M | 29.86% |
| Dec 29, 2023 | 45.74M | 48.80% |
| Dec 30, 2022 | 30.74M | -23.08% |
| Dec 31, 2021 | 39.97M | -48.56% |
| Dec 31, 2020 | 77.70M | 82.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 792.01M |
| Elite Pharmaceuticals | 718.26M |
| Glass House Brands | 574.70M |
| CytoDyn | 377.06M |
| Northwest Biotherapeutics | 373.88M |
| American Oncology Network | 345.48M |